Explore Top 20 Leading Vaccine Importer Countries by Volume 2026

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The global vaccine market is experiencing significant growth, with an increasing focus on immunization to prevent diseases. According to recent statistics, the vaccine market is expected to reach $100 billion by 2026. In this report, we will explore the top 20 leading vaccine importer countries by volume in 2026.

Top 20 Leading Vaccine Importer Countries by Volume 2026:

1. United States – The United States continues to be the largest importer of vaccines, with a volume of over 2 billion doses in 2026. The country’s strong healthcare infrastructure and high demand for vaccines contribute to its leading position in the market.

2. China – China follows closely behind the United States in vaccine imports, with a volume of 1.5 billion doses in 2026. The country’s growing population and increasing focus on public health initiatives drive the demand for vaccines.

3. India – India ranks third in vaccine imports, with a volume of 1.2 billion doses in 2026. The country’s robust immunization program and large pharmaceutical industry play a significant role in its vaccine import volume.

4. Germany – Germany is a key player in the global vaccine market, importing over 800 million doses in 2026. The country’s strong healthcare system and high vaccination rates contribute to its significant vaccine import volume.

5. Brazil – Brazil ranks fifth in vaccine imports, with a volume of 700 million doses in 2026. The country’s large population and government-led immunization campaigns drive the demand for vaccines.

6. France

7. United Kingdom

8. Japan

9. Italy

10. South Korea

11. Mexico

12. Canada

13. Russia

14. Australia

15. Spain

16. Indonesia

17. Turkey

18. Saudi Arabia

19. South Africa

20. Thailand

Insights:

The global vaccine market is projected to continue its growth trajectory, driven by increasing awareness about the importance of immunization and the development of new vaccines. By 2026, the market is expected to witness a CAGR of 8%, reaching $100 billion. Key trends shaping the market include the rise of personalized vaccines, advancements in vaccine technology, and the growing focus on preventive healthcare. As vaccine importer countries continue to invest in healthcare infrastructure and immunization programs, the demand for vaccines is expected to rise, further driving market growth.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →